Keytruda is already approved in patients with endometrial carcinoma that is microsatellite instability-high (MSI-H) or ...

Healthcare marketing agency Vue Health has set its sights on a new executive hire to lead its digital transformation. | ...

As a biosecurity crackdown on certain Chinese biopharma service providers gains momentum in Washington, the industry trade ...

British biotechs have a new ally in their struggle to secure funding. | British biotechs have a new ally in their struggle to ...

If a gene therapy is approved in the U.S., patients in Brazil can sue their government to get it cleared for use there. And, ...

Novartis’ Entresto team has earned the ire of the PMCPA. For the third time in 12 months, the U.K. drug promotion watchdog ...

As U.S. drug shortages run rampant, lawmakers are getting creative with their attempts to ease the situation. | Under the ...

In about a year after launching a revamp strategy under CEO Richard Francis, Teva has managed to return its generics business ...

In a letter to FDA Commissioner Robert Califf, M.D., the House Committee on Oversight and Accountability chairman argued that China’s influence over global pharmaceutical supply chains constitutes an ...

Apellis’ geographic atrophy drug Syfovre delivered what CEO Cedric Francois called “robust” growth in the first quarter, as its sales topped analysts’ expectations. | Apellis’ geographic atrophy drug ...

Once hailed as a landmark accomplishment for the speed with which it was developed and a shining example of British innovation, the AstraZeneca coronavirus vaccine has been grounded by the European ...

Even after consumer outfit Kenvue split from Johnson & Johnson one year ago, the company has been performing certain services for the pharma and medtech giant as part of a transition process. | Kenvue ...